Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
11.98
+0.08 (0.67%)
Feb 4, 2026, 3:00 PM CST
SHA:603439 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 160.68 | 274.03 | 292.7 | 201.28 | 152.28 | 93.95 |
Depreciation & Amortization | 74.86 | 74.86 | 36.9 | 16.19 | 11.17 | 8.11 |
Other Amortization | 1.15 | 1.15 | 0.69 | 1.66 | 0.04 | - |
Loss (Gain) From Sale of Assets | 0.17 | 0.17 | -0.59 | 0.09 | 0.15 | - |
Asset Writedown & Restructuring Costs | 0.57 | 0.57 | 0.05 | 0.18 | 0.01 | - |
Loss (Gain) From Sale of Investments | -1.96 | -1.96 | -55.16 | -10.96 | -17.87 | -2.15 |
Provision & Write-off of Bad Debts | 9.9 | 9.9 | 3.35 | 10.3 | 0.99 | 1.14 |
Other Operating Activities | 105.96 | 31.51 | 10.89 | -3.95 | 4.79 | 2.66 |
Change in Accounts Receivable | -295.56 | -295.56 | -124.07 | -79.55 | -83.04 | -33.95 |
Change in Inventory | -147.99 | -147.99 | -7.06 | -9.45 | -41.13 | 5.83 |
Change in Accounts Payable | 167.69 | 167.69 | 119.02 | 161.24 | 127.24 | -12.27 |
Change in Other Net Operating Assets | 0.15 | 0.15 | 4.14 | 6.3 | 0.76 | - |
Operating Cash Flow | 68.17 | 107.07 | 276.7 | 293.29 | 155.04 | 63.25 |
Operating Cash Flow Growth | -62.89% | -61.30% | -5.66% | 89.17% | 145.13% | -45.59% |
Capital Expenditures | -30.87 | -45.2 | -108.73 | -119.91 | -26.08 | -51.71 |
Sale of Property, Plant & Equipment | 0.54 | 0.55 | 2.05 | 0.18 | 0.05 | - |
Cash Acquisitions | - | - | -543.04 | -160.04 | - | - |
Divestitures | - | - | -0.01 | 0.65 | - | - |
Investment in Securities | -240.4 | -59.96 | 34.5 | 38 | 80.7 | -241.9 |
Other Investing Activities | -31.48 | 1.61 | 1.45 | 1.92 | -34.08 | 0.8 |
Investing Cash Flow | -302.21 | -103 | -613.78 | -266.56 | 20.59 | -292.81 |
Short-Term Debt Issued | - | - | - | - | 200 | 300 |
Long-Term Debt Issued | - | 351.22 | 504 | 205 | - | - |
Total Debt Issued | 620.86 | 351.22 | 504 | 205 | 200 | 300 |
Short-Term Debt Repaid | - | - | - | - | -200 | -100 |
Long-Term Debt Repaid | - | -309.7 | -205.45 | -200 | - | - |
Total Debt Repaid | -428.76 | -309.7 | -205.45 | -200 | -200 | -100 |
Net Debt Issued (Repaid) | 192.1 | 41.52 | 298.55 | 5 | - | 200 |
Issuance of Common Stock | 15.03 | 39.23 | - | - | 26.55 | 261.51 |
Repurchase of Common Stock | -100.41 | -100.41 | -30 | - | - | - |
Common Dividends Paid | -160.8 | -104.04 | -50.92 | -8.92 | -110.21 | - |
Dividends Paid | -160.8 | -104.04 | -50.92 | -8.92 | -110.21 | - |
Other Financing Activities | 16.52 | 23.12 | 120 | 3.8 | 2.2 | -21.51 |
Financing Cash Flow | -37.57 | -100.6 | 337.63 | -0.12 | -81.46 | 440 |
Net Cash Flow | -271.61 | -96.53 | 0.55 | 26.6 | 94.17 | 210.44 |
Free Cash Flow | 37.3 | 61.87 | 167.97 | 173.38 | 128.96 | 11.54 |
Free Cash Flow Growth | -72.85% | -63.16% | -3.12% | 34.45% | 1017.56% | -89.34% |
Free Cash Flow Margin | 2.15% | 2.89% | 10.27% | 14.43% | 13.73% | 1.83% |
Free Cash Flow Per Share | 0.09 | 0.15 | 0.41 | 0.42 | 0.31 | 0.03 |
Cash Interest Paid | - | - | - | - | - | 2.62 |
Cash Income Tax Paid | 196.82 | 210.8 | 175.31 | 116.04 | 100.28 | 64.52 |
Levered Free Cash Flow | 2.92 | 97.65 | -36.78 | 127.68 | 54.78 | -9.16 |
Unlevered Free Cash Flow | 10.31 | 106.78 | -34.2 | 130.96 | 59.99 | -7.79 |
Change in Working Capital | -283.17 | -283.17 | -12.13 | 78.49 | 3.47 | -40.47 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.